Text Size

Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents

Tsuji F., Murai M., Oki K., Seki I., Ueda K., Inoue H., Nagelkerken L., Sasano M., Aono H.


  • 2010
  • European Journal of Pharmacology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Other

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara, 630-0101, Japan; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu, 501-1193, Japan; Department of Inflammatory and Degenerative Diseases, TNO Quality of Life, Zernikedreef 9, 2333 CK Leiden, Netherlands; Functional Polymer Science Laboratory, Graduate School of Materials Sciences, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma-shi, Nara, 630-0192, Japan

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022